Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
12.39
-0.13 (-1.04%)
Jan 17, 2025, 4:00 PM EST - Market closed

Myriad Genetics Market Cap

Myriad Genetics has a market cap or net worth of $1.13 billion as of January 17, 2025. Its market cap has decreased by -24.40% in one year.

Market Cap
1.13B
Enterprise Value
1.17B
1-Year Change
-24.40%
Ranking
Category
Stock Price
$12.39

Market Cap Chart

Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $1.13B, an increase of 1,002.57%. That is a compound annual growth rate of 9.61%.

History

DateMarket Cap% Change
Jan 17, 20251.13B-9.63%
Dec 31, 20241.25B-20.67%
Dec 29, 20231.57B33.81%
Dec 30, 20221.18B-46.65%
Dec 31, 20212.20B48.19%
Dec 31, 20201.49B-26.57%
Dec 31, 20192.03B-6.80%
Dec 31, 20182.17B-8.61%
Dec 29, 20172.38B108.51%
Dec 30, 20161.14B-62.13%
Dec 31, 20153.01B21.14%
Dec 31, 20142.49B58.51%
Dec 31, 20131.57B-29.30%
Dec 31, 20122.22B25.03%
Dec 30, 20111.77B-15.91%
Dec 31, 20102.11B-15.93%
Dec 31, 20092.51B-18.54%
Dec 31, 20083.08B50.95%
Dec 31, 20072.04B64.00%
Dec 29, 20061.24B93.29%
Dec 30, 2005643.90M-6.71%
Dec 31, 2004690.20M98.11%
Dec 31, 2003348.40M-0.17%
Dec 31, 2002349.00M-71.84%
Dec 31, 20011.24B-34.15%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 653.46B
UnitedHealth Group 469.12B
Johnson & Johnson 353.99B
Novo Nordisk 341.33B
AbbVie 303.17B
Merck & Co. 247.70B
Thermo Fisher Scientific 214.07B
Intuitive Surgical 211.09B
Market Cap Rankings